SOUTH JORDAN, Utah, April 11, 2018 -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the quarter ended March 31, 2018, after the close of the stock market on Wednesday, April 25, 2018.
Merit will hold its investor conference call (conference ID 8799557) on the same day (Wednesday, April 25, 2018) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). The telephone numbers to call are (domestic) (844) 578-9672; and (international) (508) 637-5656. A live webcast will also be available for the conference call at merit.com.
ABOUT MERIT
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 290 individuals. Merit employs approximately 5,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; San Jose, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; and Singapore.
Contact: Anne-Marie Wright, Vice President, Corporate Communications
Phone: (801) 208-4167 e-mail: [email protected] Fax: (801) 253-1688


Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
Mercer International Stock Surges 45% on C$20 Million Canada Funding
OpenAI AI Agent Swarm Behind Hugging Face Hack
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Street Poller Media and The Boom of the Street Interview Ad Industry
PayPal Shares Sink as $50 Billion Takeover Bid Collapses
The Realist’s Case: Lukas Kerrebijn of RD Dubai on the Narrative Dubai’s Agents Won’t Question
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules
Trump Administration Plans New Drug Pricing Deals With Biotech Firms
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
Toyota Global Sales Fall as China Demand Slumps
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
Itochu Offers $1.56 Billion to Privatize Dentsu Soken
Shein Hong Kong IPO to Raise $1.7 Billion at $26.5 Billion Valuation 



